Literature DB >> 19540113

First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa.

Jenson Verghese1, Aiye Liang, Preet Pal Singh Sidhu, Michael Hindle, Qibing Zhou, Umesh R Desai.   

Abstract

Designing non-saccharide functional mimics of heparin is a major challenge. In this work, a library of small, aromatic molecules based on the sulfated DHP scaffold was synthesized and screened against thrombin and factor Xa. The results reveal that (i) selected monomeric benzofuran derivatives inhibit the two enzymes, albeit weakly; (ii) the two enzymes recognize different structural features in the benzofurans studied suggesting significant selectivity of recognition; and (iii) the mechanism of inhibition is allosteric. The molecules represent the first allosteric small molecule inhibitors of the two enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540113      PMCID: PMC2714770          DOI: 10.1016/j.bmcl.2009.06.013

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).

Authors:  Arjun Raghuraman; Philip D Mosier; Umesh R Desai
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

Review 2.  Peptidomimetic thrombin inhibitors.

Authors:  Danijel Kikelj
Journal:  Pathophysiol Haemost Thromb       Date:  2003 Sep-2004 Dec

Review 3.  Current issues in anticoagulation.

Authors:  Giancarlo Agnelli
Journal:  Pathophysiol Haemost Thromb       Date:  2005

4.  Rapid and efficient microwave-assisted synthesis of highly sulfated organic scaffolds.

Authors:  Arjun Raghuraman; Muhammad Riaz; Michael Hindle; Umesh R Desai
Journal:  Tetrahedron Lett       Date:  2007-09-17       Impact factor: 2.415

5.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

Authors:  Marco Guerrini; Daniela Beccati; Zachary Shriver; Annamaria Naggi; Karthik Viswanathan; Antonella Bisio; Ishan Capila; Jonathan C Lansing; Sara Guglieri; Blair Fraser; Ali Al-Hakim; Nur Sibel Gunay; Zhenqing Zhang; Luke Robinson; Lucinda Buhse; Moheb Nasr; Janet Woodcock; Robert Langer; Ganesh Venkataraman; Robert J Linhardt; Benito Casu; Giangiacomo Torri; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2008-04-23       Impact factor: 54.908

Review 6.  Heterogeneity of synthetic factor Xa inhibitors.

Authors:  Grigoris T Gerotziafas; Meyer M Samama
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

7.  Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acids.

Authors:  Brian L Henry; Jay N Thakkar; Erika J Martin; Donald F Brophy; Umesh R Desai
Journal:  Blood Coagul Fibrinolysis       Date:  2009-01       Impact factor: 1.276

8.  Novel chemo-enzymatic oligomers of cinnamic acids as direct and indirect inhibitors of coagulation proteinases.

Authors:  Bernhard H Monien; Brian L Henry; Arjun Raghuraman; Michael Hindle; Umesh R Desai
Journal:  Bioorg Med Chem       Date:  2006-08-17       Impact factor: 3.641

9.  Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators.

Authors:  Gunnar T Gunnarsson; Umesh R Desai
Journal:  J Med Chem       Date:  2002-09-26       Impact factor: 7.446

10.  Outbreak of adverse reactions associated with contaminated heparin.

Authors:  David B Blossom; Alexander J Kallen; Priti R Patel; Alexis Elward; Luke Robinson; Ganpan Gao; Robert Langer; Kiran M Perkins; Jennifer L Jaeger; Katie M Kurkjian; Marilyn Jones; Sarah F Schillie; Nadine Shehab; Daniel Ketterer; Ganesh Venkataraman; Takashi Kei Kishimoto; Zachary Shriver; Ann W McMahon; K Frank Austen; Steven Kozlowski; Arjun Srinivasan; George Turabelidze; Carolyn V Gould; Matthew J Arduino; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-12-03       Impact factor: 91.245

View more
  18 in total

Review 1.  Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.

Authors:  Qudsia Rashid; Poonam Singh; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

2.  Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold.

Authors:  Rami A Al-Horani; Akul Y Mehta; Umesh R Desai
Journal:  Eur J Med Chem       Date:  2012-06-23       Impact factor: 6.514

3.  Chemical Sulfation of Small Molecules - Advances and Challenges.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Tetrahedron       Date:  2010-04-17       Impact factor: 2.457

4.  On scaffold hopping: challenges in the discovery of sulfated small molecules as mimetics of glycosaminoglycans.

Authors:  Preetpal S Sidhu; Philip D Mosier; Qibing Zhou; Umesh R Desai
Journal:  Bioorg Med Chem Lett       Date:  2012-10-24       Impact factor: 2.823

5.  Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.

Authors:  Brian L Henry; May Abdel Aziz; Qibing Zhou; Umesh R Desai
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

6.  Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.

Authors:  Rajesh Karuturi; Rami A Al-Horani; Shrenik C Mehta; David Gailani; Umesh R Desai
Journal:  J Med Chem       Date:  2013-03-18       Impact factor: 7.446

Review 7.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

Authors:  Daniel K Afosah; Rami A Al-Horani
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

8.  Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition.

Authors:  Preetpal Singh Sidhu; May H Abdel Aziz; Aurijit Sarkar; Akul Y Mehta; Qibing Zhou; Umesh R Desai
Journal:  J Med Chem       Date:  2013-06-13       Impact factor: 7.446

9.  Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.

Authors:  Rami A Al-Horani; Pooja Ponnusamy; Akul Y Mehta; David Gailani; Umesh R Desai
Journal:  J Med Chem       Date:  2013-01-28       Impact factor: 7.446

10.  A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin.

Authors:  Daniel K Afosah; Stephen Verespy; Rami A Al-Horani; Rio S Boothello; Rajesh Karuturi; Umesh R Desai
Journal:  Bioorg Med Chem Lett       Date:  2018-02-03       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.